|
|
||||||||
CONCISE REVIEW |
Department of Hematology/Oncology, University of Freiburg Medical Center, Freiburg, Germany
Key Words. Hematopoietic stem cells (HSCs) • CD34+ • CD34- • SP cells
Monika Engelhardt, M.D., University of Freiburg Medical Center, Department of Hematology/Oncology, Hugstetterstr. 55, D-79106 Freiburg, Germany. Telephone: 49-761-270-3406; Fax: 49-761-270-3206; e-mail:
engelhardtm{at}mm11.ukl.uni-freiburg.de
Recent data have suggested that human CD34- hematopoietic stem cells (HSCs) exist, challenging the concept that HSCs necessarily and exclusively express the CD34 antigen. In mice, quiescent HSCs have been shown to be mostly CD34-, but as a consequence of 5-fluorouracil treatment or cytokine stimulation, differentiate into CD34+ cells. Of particular interest is a novel, specific marker to identify HSCs, namely the Hoechst dye efflux property, with which a distinct side population (SP) is identified. These SP cells are mostly CD34-, highly enriched for long-term repopulating cells, and durably engraft in sublethally irradiated non-obese diabetic/severe combined immunodeficient mice. Using a semiquantitative reverse transcription-polymerase chain reaction, one of the ATP-binding cassette (ABC) transporters, the breast cancer resistance protein (Bcrp) or ABC transporter G2 (ABCG2), was found to be highly expressed in SP cells as well as other primitive HSCs and to sharply drop with hematopoietic differentiation. Enforced expression of the ABCG2 cDNA resulted in a robust SP phenotype and a reduction in hematopoietic maturation. These data suggest that the Bcrp/ABCG2 gene contributes importantly to the generation of the SP phenotype, which allows for the selection of immature, pluripotent HSCs. The isolation of Bcrp/ABCG2+ cells appears to be an attractive tool to analyze and characterize HSCs, and may eventually allow for the purification of these cells for clinical purposes. In this review, current concepts on murine and human CD34- HSCs and their relationship with CD34+ HSCs are discussed.
This article has been cited by other articles:
![]() |
S. Meindl, U. Schmidt, C. Vaculik, and A. Elbe-Burger Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers J. Leukoc. Biol., October 1, 2006; 80(4): 816 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P A Samijn, P A W te Boekhorst, T Mondria, P A van Doorn, H Z Flach, F G A van der Meche, J Cornelissen, W C Hop, B Lowenberg, and R Q Hintzen Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 46 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. W. Verhaak, C. S. Goudswaard, W. van Putten, M. A. Bijl, M. A. Sanders, W. Hugens, A. G. Uitterlinden, C. A. J. Erpelinck, R. Delwel, B. Lowenberg, et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance Blood, December 1, 2005; 106(12): 3747 - 3754. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Huss, D. R. Gray, N. M. Greenberg, J. L. Mohler, and G. J. Smith Breast Cancer Resistance Protein-Mediated Efflux of Androgen in Putative Benign and Malignant Prostate Stem Cells Cancer Res., August 1, 2005; 65(15): 6640 - 6650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sosnova, M. Bradl, and J. V. Forrester CD34+ Corneal Stromal Cells Are Bone Marrow-Derived and Express Hemopoietic Stem Cell Markers Stem Cells, April 1, 2005; 23(4): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sergejeva, A.-K. Johansson, C. Malmhall, and J. Lotvall Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments Blood, February 15, 2004; 103(4): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
